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Summary For infection, viruses deliver their genomes
into the host cell. These nucleic acids are usually
tightly packed within the viral capsid, which, in turn,
is often further enveloped within a lipid membrane.
Both protect them against the hostile environment.
Proteins and/or lipids on the viral particle promote at-
tachment to the cell surface and internalization. They
are likewise often involved in release of the genome
inside the cell for its use as a blueprint for production
of new viruses. In the following, I shall cursorily dis-
cuss the early more general steps of viral infection that
include receptor recognition, uptake into the cell, and
uncoating of the viral genome. The later sections will
concentrate on human rhinoviruses, the main cause
of the common cold, with respect to the above pro-
cesses. Much of what is known on the underlying
mechanisms has been worked out by Renate Fuchs at
the Medical University of Vienna.
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Wege des Viruseintritts: am Beispiel der Erkäl-
tungsviren
Zusammenfassung Bei der Infizierung schleusen Vi-
ren ihr Genom in die Wirtszelle ein. Deren Nuklein-
säuren befinden sich gewöhnlich gut verpackt inner-
halb des Viruskapsids, welches wiederum häufig zu-
sätzlich von einer Lipidmembran umhüllt ist. Beides
schützt sie vor einer feindlichen Umgebung. Proteine
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und/oder Lipide auf dem Viruspartikel unterstützen
die Anlagerung an die Zelloberfläche und die Interna-
lisierung. Ebenso sind sie oftmals an der Freisetzung
des Genoms in der Zelle beteiligt, welches als Vorlage
für die Produktion neuer Viren dient. Im Folgenden
werden die frühen, eher allgemeinen Schritte der Vi-
rusinfektion kursorisch dargestellt, dazu gehören Re-
zeptorerkennung, Aufnahme in die Zelle und Freiset-
zung des Virusgenoms. ImHinblick auf die genannten
Abläufe liegt der Schwerpunkt in den weiteren Ab-
schnitten auf humanen Rhinoviren als Hauptursache
für den Schnupfen. Viele der bisherigen Erkenntnis-
se in Bezug auf die zugrunde liegenden Mechanis-
men sind von Renate Fuchs, Medizinische Universität
Wien, erarbeitet worden.
Schlüsselwörter Endozytose · Rhinovirus · Genom-
freisetzung · Lysosom · Kapsidöffnung
Introduction
The first encounter between a virus and its host cell
usually takes place via a protein, a proteoglycan, an
oligosaccharide, or a glycolipid exposed on the cell
surface that is recognized by cognate viral surface
components. Only few viruses can subsequently pen-
etrate directly from the plasma membrane into the
cytosol of the host cell; the large majority rather ex-
ploits cellular entry pathways by travelling inside a
membrane vesicle. Under physiologic conditions,
these cell surface molecules serve as nutrient trans-
porters or signal transduction receptors, or in cell–cell
interactions and attachment, amongst other things.
In the context of viral infection they have been termed
“viral receptors” although the cell obviously does not
make them for the purpose of becoming infected.
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Viruses not only abuse membrane receptors but
also soluble molecules, as a bridge to a plasma mem-
brane protein or to bind to virus-specific antibodies
that are present in the serum as a consequence of
a previous infection. The latter, in turn, can then
bind Fcγ-receptors present at the surface of some spe-
cialized cells and thus link the virus to them. For
instance, virus-specific immunoglobulin G (IgG) can
enhance infection by various flaviviruses, including,
e.g., Dengue virus, rather than protecting the host
against infection [1]. Other examples are the bind-
ing of apolipoprotein-E to both hepatitis C virus and
heparan sulfate proteoglycans, which also leads to
a connection between the virus and a cell surface
component [2], and growth arrest-specific 6 (Gas6)
bridging TAM receptors (various receptor tyrosine ki-
nases) with phosphatidylserine that is present in the
viral lipid membrane of Dengue and Vaccinia virus
[3]. So, viruses have evolved to make use of whatever
is available for attaching to and entering the host cell.
Clearly, the presence or absence of a cognate viral re-
ceptor is a major but not the only factor in species and
tissue tropism of a given virus [4]. It is of note that tar-
geting viruses with oncolytic potential to tumors for
their infection and destruction has been achieved by
copying and exploiting this strategy [5].
Following the mutual recognition, the viral particle
is taken up into the cell, either constitutively or trig-
gered through its interaction with the receptor. The
many identical subunits of a virion (i.e., a viral parti-
cle) render it multivalent; this can lead to clustering
of, e. g., receptor tyrosine kinases or of integrins. For
example, Vaccinia virus triggers activation of phos-
phatidylinositol 3-kinase (PI3K)/Akt in an integrin β1-
dependent manner, suggesting that this particular sig-
naling pathway is essential for virus endocytosis [6].
Entry into the cell then engenders lipid vesicle traf-
ficking processes. Reminiscent of the natural ligand,
most intruding viruses become trapped where shal-
low membrane pits form; upon further membrane
bending, a deep invagination is produced and finally
severed from the plasma membrane in the form of
a closed vesicle. The vesicle pinches off the inner
side of the plasma membrane and carries its viral
cargo, together with some extracellular fluid, through
the crowded cytoplasm towards its intracellular des-
tination. The transport vesicles undergo maturation
by fusing with other vesicles, severing, and content
sorting, all taking place during their voyage inside
the cell. The vesicular membrane composition and
intravesicular milieu continuously change along this
route. Molecular machines, such as dyneins and ki-
nesins, are involved in transporting virus-containing
vesicles—or free virus particles—along actin fibers or
microtubules [7–9].
Material inside the vesicle lumen is topologically
extracellular and thus requires that either the entire
virus or at least its genome penetrate the delimit-
ing membrane to attain the cytosol. This occurs as
soon as membrane composition, pH, ionic environ-
ment, etc. have become optimal for this process and
a given virus; it can happen in early endosomes, late
endosomes, recycling endosomes, macropinosomes,
the endoplasmic reticulum, in various subcompart-
ments of the Golgi, and even in lysosomes with their
interior full of hostile hydrolytic enzymes.
Membrane penetration is usually preceded by or
occurs in concert with conformational changes of
viral surface proteins and/or the whole virion shell
itself. In many cases, these structural changes require
that an envelope protein, such as the hemagglu-
tinin of influenza viruses, has been proteolytically
cleaved during maturation [10]. A hydrophobic or
amphiphilic fusion peptide then becomes exposed
and inserts into the plasma membrane; in non-en-
veloped viruses, membrane destabilization or even
disruption is brought about by the release of “mem-
branolytic peptides”, small amphipathic viral proteins
[11]. Another means of membrane destabilization
was shown for canine parvovirus, which has a phos-
pholipase A(2)-like domain in the N-terminus of its
capsid protein VP1, whose enzymatic activity makes
the membrane permeable for dextran of 3 kD but not
of 10 kD [12]. Recently, the perfidiousness of viral
entry has been demonstrated for adenovirus; this
virus induces small pores via its membrane lytic pro-
tein-VI, which triggers calcium-mediated lysosomal
exocytosis repair pathways and lipid signaling that
finally facilitates uptake of the pathogen [13]. In all
these cases, once the nucleic acid(s) has arrived in the
cytosol, depending on the type of virus and the na-
ture of its genome, replication is either initiated right
there, or after it has been shuttled to the nucleus.
The present article is aimed at providing a brief
overview on these early events of viral infection. Its
extent is far from covering all aspects of these complex
and in part poorly understood processes. I apologize
for citing only few, mostly recent and in part arbitrar-
ily chosen publications referring to examples out of
the about 17,500 papers found in a PubMed literature
search for “virus AND entry” at the time of writing.
For recent excellent and more in-depth reviews on vi-
ral entry and uncoating, see, for example, [14–23].
Naked and enveloped viruses
Viruses come essentially in two distinct flavors; either
carrying a lipid membrane envelope decorated with
viral proteins, or naked, i. e., without any lipid. The
former have built-in machinery for penetration of
their capsid into the cytosol via fusion of viral with
cellular membranes. Most often, this process is trig-
gered by the acid environment (pH between about
5 and 6) established inside the endocytic vesicles
during their maturation into late endosomes [24–26];
there are only few viruses, including human immun-
odeficiency virus (HIV) and herpes simplex virus-1,
which do not require an acidic environment and can
212 Viral entry pathways: the example of common cold viruses K
main topic
Fig. 1 Fusionof enveloped
viruseswithacellularmem-
brane. aAviral envelope
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thus even fuse with the plasma membrane at neutral
pH [27, 28]. In any case, a structural change of a con-
formationally metastable viral surface protein needs
to occur; this results in exposure of a previously
hidden fusion peptide, usually a stretch of amphi-
pathic and/or hydrophobic amino acid residues. The
metastable state is often prepared during maturation
via cleavage of the protein, setting the trigger for this
sequence to insert into the cellular membrane upon
arrival in a low-pH environment. The ensuing confor-
mational change forces the viral membrane and the
cellular membrane into close apposition. The result is
hemifusion (i. e., an intermediate state without con-
tent mixing), and finally the complete melding of the
two membranes, including lipid mixing and delivery
of the nucleocapsid into the cytosol (Fig. 1).
Whereas membrane fusion is quite well under-
stood, penetration of naked viruses still holds a num-
ber of open questions; in principle, access of the
viral genome to the cytoplasm might either occur via
disruption of the virus-containing vesicle—with the
entire virion, together with other endosomal content,
being released into the cytosol—or via pores of lim-
ited size in the endosomal membrane. Such pores
are presumably lined by domains of viral proteins
forming a channel contiguous with a pore in the viral
shell. The holes in the virus capsid open upon a con-
formational switch, again most often triggered by the
acidic pH and sometimes assisted by the viral recep-
tor [29]. As described in more detail at the end of this
article, by using common cold viruses as examples of
cellular entry by non-enveloped viruses, Renate Fuchs
has been working for many years on unravelling viral
uptake and trafficking of viruses inside the cell, and
the transfer of the viral RNA genome into the cytosol
(see reviews [30, 31]). Because at least three different
receptors are used by the three rhinovirus species, it is
no wonder that they enter host cells via different en-
docytic pathways [32–34]. As a result, uncoating, i. e.,
release of their positive-sense single stranded RNA
genome, might occur in different cellular compart-
ments via different mechanisms, which is the subject
of the last sections of this article.
Viral attachment—role and function of the
receptors
Parameters governing interactions between viruses
and their cognate receptors have been investigated in
vitro mostly by surface plasmon resonance method-
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ology, for an example, see [35]. Virus is immobilized
on a dextran-modified metal surface, a solution con-
taining recombinant soluble receptor (i. e., lacking the
membrane anchor) is constantly flown over the chip,
and binding is monitored online as a mass-dependent
change of the surface plasmon resonance angle. On
washing with plain buffer, previously bound receptor
dissociates, returning the signal to baseline. From
these binding/unbinding profiles, the on and off rates
and the affinity constants can be derived.
Capillary electrophoresis was demonstrated to
yield information on the number of soluble recep-
tors bound per virion by resolving virus with zero
and up to 12 attached receptors. In addition, a rough
estimate of the affinity constant could be derived
[36]. Here, both components are free in solution and
their concentrations and those of their complexes at
different stoichiometry are measured.
Atomic force microscopy can deliver a detailed en-
ergy landscape of the unbinding forces when the virus
is pulled away from the receptors and the (noncova-
lent) bonds between them are ruptured sequentially
[37–39].
Finally, information on the spatial arrangement of
the five ligand-binding modules of a soluble very-
low density lipoprotein receptor (VLDLR) concatemer
construct on the surface of a rhinovirus could be
inferred from fluorescence resonance energy trans-
fer between its N- and C-termini. Quenching was
recorded upon attachment. This demonstrated that
the ends indeed come close to each other when the
receptor molecules wrap around each of the vertices
at the 5-fold axes of icosahedral symmetry [40].
Although providing valuable information, the ex-
perimental conditions of at least the first two methods
are not representative of the in vivo situation where
the receptor is anchored in the cellular membrane. In
this latter context, binding of a virus to its membrane
receptor is not always as straightforward; it might be
preceded by relatively unspecific electrostatic inter-
actions with charged molecules at the cell surface,
such as heparan sulfate or sialic acid, either tether-
ing the virions to the plasma membrane and thus in-
creasing their local concentration, or rather hamper-
ing their access to the receptor(s) and thus decreas-
ing their local concentration [41]. Such effects are
difficult to investigate; live-cell single-particle track-
ing methods [42] have suggested that some viruses
remain on the cell surface for extended periods of
time wandering. According to the “seek and stick”
paradigm, a virus would thus diffuse in the plane of
the membrane, bound weakly and rather unspecifi-
cally to main components of the glycocalyx, such as
proteoglycans, glycolipids, etc., until it encounters its
specific, higher-affinity receptor(s), usually present at
lower density. Single receptor molecules might cluster
during this diffusion in two dimensions, as a conse-
quence of the multivalence of the virion. This can
increase the avidity of the interaction, and, at the
same time, slow down the speed of diffusion, i. e.,
the virus would collect several receptors on this ex-
cursion. In some specific cases, such avidity effects
might turn on the endocytosis machinery at a site of
multivalently attached virus by relaying signals into
the cell [43]. There are also other ways one can envis-
age the sequence of events leading to formation of a
virus–receptor complex ready to be engulfed; to give
just one example, the high-affinity receptors might be
confined to special microdomains (e. g., lipid rafts en-
riched in cholesterol), requiring the virus to first ar-
rive in such microdomains by diffusion in order for
tight binding to become possible [14]. High-speed
particle tracking experiments have suggested that the
plasma membrane is not a two-dimensional contin-
uum fluid, but rather contains submicron compart-
ments with different fluidity [44]. Reminiscent of sig-
nal transduction via bi- or oligomeric natural ligand
molecules, the cytoskeleton might also be involved
in limiting virus movements or in relaying viral en-
try via signals triggered through virus-induced clus-
tering of the membrane receptors. It must be taken
into account that the number of receptor molecules
simultaneously attached to a single virion might im-
pact on efficiency and speed of the uptake, as well
as on uncoating later in the entry pathway, e. g., by
exerting disruptive strain. For example, uncoating of
HIV-1 was shown to depend on dynein and kinesin 1.
It was suggested that these motors exert mechanical
forces “tearing apart the virion” [45]. Another exam-
ple is the pull of kinesin on adenovirus capsids when
bound to the nuclear pore complex via Nup214 [46].
In addition, transport of receptor-bound virus to sites
of active endocytosis (e. g., from filopodia to the cell
body) has been observed.
Uptake of the virus into the cell
Uptake of cargo, be it for nutrition, signaling, or for
downregulating signals by ferrying receptor–ligand
complexes to lysosomes for degradation, can occur
mainly by i) clathrin-mediated endocytosis (CME),
ii) caveolin-mediated uptake (CavME), iii) macropino-
cytosis, and iv), poorly characterized uptake mecha-
nisms involving neither clathrin nor caveolin. These
processes are usually summarized under the name
of endocytosis. It is of note that often none of these
pathways is exclusively exploited by a given virus;
even more so when one entry route is blocked, e. g.,
by a specific inhibitor. In this situation, the cell might
compensate by upregulating another pathway that
will then also be used by the virus [47]. By the same
token, a given virus might prefer different pathways
in different cells [48].
Various components of the internalization machin-
ery can be targeted by chemical inhibitors or ablated
through genetic approaches such as RNA knockdown
[49]. Recently, high-throughput screening of gene
knockout libraries generated via CRISPR/Cas9 allowed
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identification of factors involved in uptake of bacte-
rial toxins [50]; obviously, the same techniques can
be used to find genes involved in viral endocytosis.
Nevertheless, such results are sometimes ambiguous,
either because of low specificity, redundancy of the
targeted factors, or because the inhibited components
take part in more than one pathway. Systematic and
bioinformatics-guided RNAi screens have recently
been adopted to identify proteins of the host cell
involved in uptake of viruses [51–53]. This method
involves cell transfection with short ‘interfering RNAs’
with complementarity to sequences of a target mRNA
to be silenced. Their hybridization results in their
degradation and consequently in downregulation of
the encoded protein.
Finally, haploid mutant cell libraries—with each
clone having a different gene inactivated—have been
prepared. Screening such libraries for reduced vi-
ral replication has led to the identification of host
components essential in virus uptake and to drugs
specifically inhibiting the function of these factors [54,
55]. Such cellular components are clearly less prone
to escape by viral mutation and are increasingly con-
sidered as possible targets for antiviral drugs.
Clathrin-mediated endocytosis
CME (Fig. 2 pathway 1) is the by far best under-
stoodmechanism of cellular uptake (for an instructive
movie see ref [56]). Many ligands (e. g., low-density
lipoprotein, chylomicrons, Fe3+-saturated transferrin,
growth factors, etc.) are channeled into this system
via receptors whose cytoplasmic tails feature amino
acid (AA) sequence motives like Asn-Pro-X-Tyr (X is
any AA) or two consecutive leucines (the di-leucine
motive) [57]. These signatures are recognized by the
adapter complex AP-2 that tethers soluble clathrin
monomers to the inner side of the plasma membrane
for polymerization into a coat easily seen under the
electron microscope. More than fifty other compo-
nents are involved in CME; the membrane is curbed to
build a shallow basket or pit that subsequently grows
to form an invagination that becomes constricted and
pinches off the plasma membrane. The main players
in this process are the GTPase dynamin, the mem-
brane-bending protein amphiphysin, and the AP-2
binding protein eps15 [58]. Finally, a clathrin-coated
vesicle is formed [59]; once free in the cytosol, this
coat is again removed under ATP hydrolysis, making
the membrane accessible for fusion and fission with
other vesicles [60]. During these maturation/fusion
steps new proteins are acquired, amongst them the
vesicular ATPase complex that acidifies the vesicular
lumen by pumping H+ into the vesicle, creating an
increasingly acidic intravesicular environment and
a membrane potential [26]. The endocytic vesicles
move on and finally fuse with lysosomes, the disas-
sembly and degradation factories of the cell. Thus,
viruses need mechanisms to release their precious
Fig. 2 Simplified viewof themajor entrypathways. 1Clathrin-
dependent endocytosis. Clathrin-coated (CC) pits are formed
at theplasmamembraneandmature into clathrin-coatedvesi-
cles. Thesearesevered fromtheplasmamembranebydynamin
that forms ringsaround thenecks. Once inside thecytosol, the
coat is removedbyuncoatingATPases,making themembrane
accessible for fusionwithother vesicles. Maturationand fusion
results in the formationof early endosomes (EE); thesemature
further into late endosomes (LE) and/or fusewithLE.During the
process, thepHcontinuouslydecreases fromneutral to about
5.6, dependingon thecell type. LEfinally fusewith lysosomes
(L), where the luminal content isdegradedbyhydrolaseswhose
activity ismaximal aroundpH5. A side step fromEE leads to
theperinuclear recycling compartment (PNRE). Some ligands
(e. g., transferrin)are returnedto theplasmamembranevia recy-
clingendosomes (RE).2Caveolae (Cav) featureaparticular lipid
composition rich in cholesterol andglycosyl phosphoinositol-
linkedproteins, andamore translucent coat of cavin. Theycan
beshuttled toendosomesbutalso to theGolgi (notshownhere).
3Macropinosomes (MP) formunder thedirectionof actin fibers
and transportextracellular liquidbutalsomembrane-bound lig-
ands. They travel to lysosomes for fusionanddegradationof
their content, but there is a connection toEEaswell. Vesicles
areoften ferriedalongactin fibersandmicrotubules viamotor
proteins like kinesin anddynein (as indicated forRE)
genome undamaged into the cytosol to avoid de-
struction at the end of this itinerary by the aggressive
lysosome.
CME can be blocked by variousmore or less specific
chemical inhibitors, amongst them chlorpromazine
and dynasore, by siRNAs (small interfering RNAs, see
also RNAi above) knocking down the clathrin heavy
chain and/or dynamin-2 (dyn2), and by expression
of a dominant-negative form of this latter protein
(dynK44A) or of eps15 lacking the modules that interact
with AP2 [61]. Chlorpromazine relocates clathrin and
the adaptor complex AP-2 from coated pits to vesicles
[62]; dynasore, the dyngos, dynols, and the iminodyns
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are all inhibitors of dynamin’s GTPase activity and, as
such, target all processes involving dynamins [63, 64].
Pitstop inhibits interaction of amphiphysin with the
amino terminal domain of clathrin and was thus ex-
pected to be specific for CME. However, it appears to
also affect various forms of clathrin-independent en-
docytosis (CIE) [65]. Other measures, like potassium
depletion or incubation of the cells with hypertonic
sucrose, have been shown to dissociate polymerized
clathrin and thereby inhibit entry of viruses by CME
[66]. So, the best way to identify the main entry path-
way exploited by a given virus is via employing several
of the methods mentioned above in parallel.
Caveolae-mediated endocytosis (CavME)
There are substantially fewer reports on viral entry in-
volving caveolae than clathrin-coated pits, and only
few viruses have been found to preferentially exploit
this route. In addition, early reports on caveosomes,
vesicles presumably derived from caveolae [67], in vi-
ral entry have been partially superseded by later re-
sults, e. g., see the case of echovirus 1 [68, 69]. Mor-
phologically, caveolae are easily distinguishable from
clathrin-coated pits; in the transmission electron mi-
croscope they show a typical elongated form remi-
niscent of round-bottom flasks extending into the cy-
tosol, with a cavin coat that is less electron-dense than
clathrin [70]. Their necks are open at the cell sur-
face ([71]; Fig. 2 pathway 2). Apart from caveolin-1, a
main component, caveolae possess a particular lipid
composition with high cholesterol and glycosphin-
golipid content, and accumulate membrane proteins
with glycosylphosphatidyl-anchors; as caveolae origi-
nate from cholesterol-rich lipid rafts, their lipid com-
position is similar. Viruses that might enter via this
route include simian virus 40 (SV40), polyomavirus,
echovirus 1 (but see above), certain coxsackieviruses,
and some others [67]. Compared to CME, entry via
caveolae is slow, i. e., the viruses might remain for
hours unchanged in caveosomes, a distinct class of
caveolin-1-containing endosomes identified in some
cell lines. Similar to the reports on echovirus 1, SV40
entry in the absence of caveosome formation was also
demonstrated. This questions the role of caveolin in
the uptake of these particular viruses [72].
There are inhibitors that are, to some low extent
only, specific for the caveolar pathway, such as the
protein kinase inhibitor genistein. A combination of
the cholesterol-sequestering drugs nystatin or filipin
with the cholesterol-synthesis inhibitor progesterone
blocks the formation of caveolae as summarized in
[73]. Since severing of caveolae from the plasma
membrane also involves dynamin, drugs blocking its
function also block the caveolar pathway (see above).
Macropinocytosis
During macropinocytosis cellular protrusions are ac-
tively formed and fold back onto the plasma mem-
brane under the direction of actin assembly (Fig. 2
pathway 3; [74]); the process primarily takes up liq-
uid but also material bound to the region where the
vesicles form [75]. Few viruses have been shown to
definitely enter via this pathway [76]; amongst them
a murine amphotropic retrovirus [77], which this was
inferred from its uptake into fibroblasts lacking cave-
olin or dynamin. Cytochalasin and latrunculin block
both macropinocytosis and actin-dependent phago-
cytosis that is responsible for engulfment of larger
particles, such as bacteria, and were shown to also re-
duce entry of this virus. Amiloride acts on Na+/H+ ex-
changers at the plasma membrane and has been used
as a moderately specific inhibitor of macropinocyto-
sis. At least in A431 cells it was shown to increase
the submembranous pH that is normally lowered by
metabolically generated acid; this, in turn, inhibits ac-
tivation of GTPases involved in actin remodeling [78].
However, amiloride and it derivatives can also block
later steps in viral synthesis, like replication of the nu-
cleic acid; therefore, results with this drug need to be
controlled with much care. The inhibitor profiles are
often not exactly the same for the uptake of different
viruses, making it difficult to term the process “typ-
ical” macropinocytosis. This might result from the
virus exploiting other pathways in parallel to different
degrees.
“Virus-made invaginations”
The unique structure of the GM1 ganglioside, which
can act as an SV40 receptor, together with the multi-
tude of binding sites on the virion can promote mem-
brane curvature and internalization by itself, in the
absence of any invagination-promoting coats. Re-
markably, even long tubules containing a multitude
of viruses arranged as pearls on a string were ob-
served [79]. Similarly, virus-like particles derived from
a norovirus were shown to induce negative membrane
curvature on binding to glycosphinoglipids present
in giant unilamellar vesicles [80]. Although different
from “pure” lipid-mediated endocytosis studied in li-
posomes [81], a similar effect might be responsible for
deep invaginations seen around a rhinovirus (RV-A2)
when bound to concatemers of five copies of repeat 3
of VLDLR, recombinant high-affinity protein receptors
that were attached to liposomes via a his6-tag, which,
in turn, was bound to Ni-nitrilotriacetate (Ni-NTA)
lipids incorporated in the lipid bilayer [82]. Clearly, all
cellular components involved in membrane-bending
and fission were lacking in these latter highly artificial
systems and no vesicles were observed inside the li-
posomes; formation of these pits and tubules might
be strongly dependent on concentration, affinity, and
size of the receptors. Similar tubules filled with inter-
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cellular adhesion molecule 1 (ICAM-1)-binding rhi-
noviruses had been observed in rhabdomyosarcoma
cells overexpressing this receptor [33]. It is unknown
whether a similar entry mechanism operates in vivo
in cells expressing the respective receptors—protein
but not lipid—at high concentration.
Entry of common cold viruses—a paradigm for
naked virus entry
Rhinoviruses (RVs) are the main cause of common
colds. They are of enormous economic impact, es-
timated at about 25 billion USD per year in the USA
due to absences from work, spending for medicines,
and doctors’ visits [83]. Infections are recurrent and
often involve different RV serotypes. Nevertheless,
immunization with recombinant viral proteins seems
to result in antibodies more broadly cross-reacting;
however, again only with low cross-neutralization ef-
ficiency [84–87]. A major challenge for production of a
vaccine is the large number of different viral serotypes,
which would require the formulation to contain at
least one representative of each cluster of the (weakly)
cross-reacting antigens, which is difficult to realize.
Rhinovirus receptors
RVs are of comparatively simple architecture; an
icosahedral shell with T = 1, P = 3 symmetry is built
from sixty copies of four different capsid proteins, VP1
through VP4, that enwrap a single-stranded positive-
sense RNA genome of roughly 7100 bases in length.
The particle is about 30 nm in diameter. Within the
family picornaviridae, the Enterovirus genus includes
more than 150 RVs divided into three species, RV-
A, RV-B, and RV-C. It also includes the three po-
liovirus serotypes, the coxsackieviruses, and the well-
known enterovirus EV71—causing epidemics of hand-
foot-and-mouth disease with severe complications
[88]—amongst many others. Despite high similarity
of the nucleotide sequence of their RNA genomes [89]
and three-dimensional structures, RVs recognize three
different classes of receptors; twelve RV-A use mem-
bers of the low-density lipoprotein receptor (LDLR)
family for cell entry and constitute the minor receptor
group [90–93]. Ninety species, comprising represen-
tatives of both species A and B, the major receptor
group, bind ICAM-1 [94]. And finally, about fifty RV-
C might bind the cadherin-related family member 3
(CDHR3), as so far explicitly demonstrated for three
representatives [89, 95, 96].
The different receptors are unrelated and exhibit
different AA sequences, 3D-structures, and functions
in the context of cell metabolism. Whereas LDLRs are
ubiquitous and highly conserved throughout animal
species, ICAM-1 is not expressed in all cell types and
is less conserved; major-group RVs only bind the hu-
man and primate version of ICAM-1. Systematic hu-
manization of the mouse protein allowed pinpointing
AA residues important for recognition [97]. The nat-
ural human ICAM-1 Kilifi variant substantially differs
in affinity for RV14 and RV16 [98], allowing for esti-
mation of the impact of a single AA mutation on virus
recognition. Whereas numerous 3D-structures of viri-
ons belonging to the major andminor receptor groups
in complex with their cognate receptors are available,
most of what is known on CDHR3 interaction with
HRV-Cs is derived from homology modelling [99] and
no 3D structure is yet available. Probably, this is due
to the low yield of virus in cells transfected to express
the receptor; no established cell line that would be-
come infected by RV-Cs has been found so far.
Members of the LDLR family possess various num-
bers of highly conserved ligand binding modules,
seven in LDLR, eight in very-LDLR (VLDLR), and 31 in
LDLR-related protein (LRP) [100]. Single modules ex-
hibit very low binding affinity; however, simultaneous
binding of several modules results in a considerable
increase in avidity [101, 102]. Although not antici-
pated in initial cryo-EM work [103], a recombinant
concatemer of five copies of module 3 of VLDLR was
later demonstrated to arrange around a five-fold sym-
metry axis of the virus in a ring-like structure [40,
104, 105]. Interestingly, binding of a recombinant
concatemer (i.e., five identical repeats fused head to
tail) of repeat 3 of VLDL neutralized infectivity not
only via competition with the natural receptor, but
also via inhibiting the structural changes necessary
for the release of the RNA [102, 106, 107]. Mutations
of single VLDLR modules and their display on phage
[108], as well as systematic exchange of human LDLR
repeats for their mouse homologues [109] allowed
the requirements of particular AA residues for viral
recognition to be defined. The different modules
in LDLR and LRP exhibit various degrees of affinity;
therefore, they most likely contribute to the overall
binding avidity to a different extent. The footprint of
the receptor modules indicates that the interactions
are mostly governed by charge and shape comple-
mentarity [90, 105, 110]. Since VLDLR is probably not
expressed in the nasal mucosa [111, 112], presumably
only LDLR and LRP are used by minor-group RVs for
cell entry and infection in vivo [92]. In contrast to
ICAM-1 (see below), LDLRs merely function as vehi-
cles for virus entry. However, they might have a role
in release of the virus from its receptors in the late en-
dosomal compartment through the pH-dependence
of the binding affinity [113].
LDLR molecules wrap around each of the 12 star-
like mesas at the five-fold axes by engaging several,
presumably up to five, ligand-binding repeats [104,
105]. In LRP, the 31 repeats are arranged in groups
with spacers in between. Thus, it is possible that LRP
can bind simultaneously to more than one pentamer
because of its length. At maximal occupancy the stoi-
chiometry (virus: soluble receptor) is 1:12 for recom-
binant VLDLR and, presumably, LDLR [113–116], but
maybe less for LRP.
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ICAM-1, the receptor of major-group RVs [117], be-
longs to the immunoglobulin (Ig) superfamily and has
five Ig-domains [118], with only the first one (D1)
being engaged in RV binding [119]; the second do-
main appears to be necessary for correct folding of
D1. Cryo-EM reconstructions of complexes between
representative RVs and soluble ICAM-1 show the lat-
ter sticking out from the canyon, upright with a slight
outward inclination [120]. The theoretical stoichiom-
etry at maximal occupation is 1:60 for ICAM-1 [121].
According to the canyon hypothesis, receptor-
recognizing AA residues would be inaccessible for
antibodies due to the narrowness of the canyon [122,
123]. Nevertheless, at least one monoclonal antibody
(MAb) reaching far into this valley has been isolated.
The paratopes of IgG molecules and of ICAM-1 are
quite different and AA residues recognized by the MAb
differ from those recognized by ICAM-1. This allows
for escape from antibody neutralization via mutation
without substantially changing receptor binding [124].
This also explains why ICAM-1 binds many different
RVs, whereas MAbs targeting residues at the canyon
floor and cross-reacting with several RV serotypes
have not been described. On the other hand, for
minor-group viruses, the receptor-binding site is en-
tirely exposed and available for antibody recognition.
Again, no cross-reacting antibodies targeting residues
within the receptor footprint have been reported; in
this case, this might be due to the necessity to bind
more than one symmetrically-related site for appre-
ciable avidity, which is impossible for IgGs because of
their lower valence, geometry, and steric constraints.
It has not been addressed whether IgMs, which would
at least allow pentavalent attachment to such sites,
might be better cross-reactors, assuming that the ge-
ometry and flexibility would allow such interactions.
A particular feature of ICAM-1 is its “catalytic” ac-
tivity; in vitro, interaction with cognate RVs at a tem-
perature above 30 °C leads in some, but not all, ma-
jor-group RVs to uncoating at neutral pH, a process
remotely similar to catalysis [121, 125–127]. Since ini-
tial low-affinity binding is followed by an increase in
affinity it is likely that the receptor stabilizes an “open”
conformation temporarily adopted by the virus via
“breathing” [127]. This might allow ICAM-1 to pen-
etrate more deeply into the canyon [128]. Breathing is
also responsible for the transient exposure of capsid-
internal protein sequences at the N-terminus of VP1
and the myristoylated VP4 that are not accessible at
lower temperature [129, 130]. Thus, ICAM-1 can be
seen as a wedge driven into the canyon just when it is
expanded. This would shift the equilibrium between
the two conformations towards the more “open” one.
The “priming” for uncoating strongly depends on the
temperature and the concentration of soluble ICAM-1,
which agrees with the dynamic structural rearrange-
ments [131, 132]. However, receptor-driven uncoat-
ing is not very efficient at neutral pH but is aided
by acidification [133]. RV-A89 adapted to grow in
cells devoid of ICAM-1 was more readily neutralized
by soluble ICAM-1. This might indicate that a de-
crease in stability is necessary for becoming less de-
pendent, and finally independent—like minor-group
RVs—from the destabilizing activity of ICAM-1 and al-
lowing the use of a receptor that “just binds but does
not uncoat” [134]. The concentration range of solu-
ble ICAM-1 required for 50% neutralization of differ-
ent serotypes at physiologic pH extends over about
1.7 logs [135]; whether competition with the cellu-
lar receptor or ICAM-1-catalyzed uncoating is primar-
ily responsible for neutralization cannot be inferred
from these simple measurements. It is noteworthy
that dimerization of the ICAM-1 molecule increases
its neutralization potency [136], which might be a me-
chanical phenomenon resulting from generation of
strain upon bivalent binding with suboptimal geom-
etry. The “hit-and-run” uncoating of poliovirus [137]
and EV71 by monoclonal antibodies [138] might be
related phenomena.
The ratio between the number of physical rhi-
novirus particles and the number of infectious parti-
cles is in the range of 24–240 under mild purification
conditions using metrizamide density gradients, and
can be much higher when harsh conditions such
as CsCl-gradient centrifugation are used [94]. It is
not known whether this ratio is lower for unpuri-
fied virus. It is thus necessary to not only follow the
physical particles on their way into the cell but also
to demonstrate that a given pathway leads to initia-
tion of infection. Therefore, it is essential to assess
“productive” infection as well. Preferentially, such
assays should target an early stage of the viral repli-
cation cycle to avoid secondary effects of inhibitors
and/or particular experimental incubation conditions
on later stages such as RNA replication, assembly,
maturation, and release of progeny. Considering that
i) uncoating results in release of the viral RNA into
the cytosol, that ii) this RNA is translated, and that
iii) the resulting polyprotein is cleaved to release the
2A protease, which, in turn, cleaves the eukaryotic
initiation factor 4G (eIF4G), the latter can be corre-
lated with uncoating. The more RNA arrives in the
cytosol the more eIF4G is cleaved. The tiny amounts
of the viral proteinase P2A that becomes translated
from the incoming viral RNA have thus been used to
demonstrate viral uncoating without having to wait
until replication has set in [33].
Uptake and uncoating of the minor receptor-
group prototype RV-A2
LDLR and LDLR-related protein 1 (LRP1) possess in-
ternalization sequencemotives in their N-terminal cy-
toplasmic tails that typically associate with the AP-2
complex, which, in turn, assembles the clathrin coat
at the cytoplasmic side of the plasma membrane giv-
ing rise to clathrin-coated pits. Indeed, uptake of the
minor receptor-group prototype RV-A2 into HeLa-H1
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Fig. 3 Simplified viewof theentryofmajor receptor-group
rhinovirusesbinding ICAM-1 (RV-B14,RV-A89), theminor
receptor-group rhinovirusbindingLDLR (RV-A2), and thehep-
aransulfate-bindingvariantof themajor-groupvirusRV-A8v.On
attaching to their respective receptors, RV-A2andRV-A89are
takenup into coatedandRV-B14andRV-A8v into non-coated
vesiclesand tubules. RV-A2 is shuttled to early endosomes
where thepH isabout 5.8 inHeLacells. On further acidification
to apHbelow5.7,RV-A2 releases theRNA throughapore and
the remaining capsidproteinsare transferred to lysosomes
for degradation. RV-A8ventersbyapathwaynot involving
clathrin inmacropinocytic vesiclesbutalso tubules (notshown);
whether it releases itsRNA throughholes in themembraneor
via lysis of theendosomes isnot known. RV-B14 lyses theen-
dosomalmembraneandRNA, aswell as viral protein, arrives in
thecytosol. In this case, no lysosomal degradation isobserved.
RV-A89 travels to recycling endosomes for uncoating,whether
it disrupts theendosomes isnot known. LDLR low-density
lipoprotein receptor, ICAM-1 intercellular adhesionmolecule
1,ELearly endosome,LL late endosome,PNRCperinuclear
recycling compartment
cells was demonstrated to be impeded by most in-
hibitors and interventions generally accepted to block
CME, as summarized in Tab. 1 and Fig. 3. However,
as mentioned above, endocytosis of RV-2A was also
seen to be diverted to a non-clathrin-dependent route
when the former pathway was curtailed by overex-
pression of the dominant negative dynamin 1 mutant
K44A [139]. So, at least in HeLa-H1 (and in Rhab-
domyosarcoma cells), RV-A2 primarily, but not exclu-
sively, enters via clathrin-dependent endocytosis [33,
140].
Once inside endosomal carrier vesicles (ECV) or
late endosomes, RV-A2 is believed to dissociate from
its receptor, a process partly promoted by the acid-
dependent intramolecular competition of the beta-
propeller domain of LDLR with the bound virus for
the ligand binding domains [114, 115] and partly by
the conversion of the native virus into the expanded
A-particle that lacks affinity for the receptor. Both
effects occur at about pH 5.7, usually attained in
ECVs and late endosomes, depending on the cell
type [113, 141, 142], and are inhibited when the pH
is increased by incubation with weak bases, proton
carriers, and inhibitors of H+-ATPases [133, 143–145].
The affinity for the receptor is lost because of the
altered conformation of the subviral particle within
the receptor footprint [146, 147]. Presumably the
particle is handed over to the membrane during its
formation, a process assisted by the myristoylated
VP4 and N-terminal sequences of VP1 both exiting
from the virion and inserting into the lipid bilayer
creating pores lined by amphiphilic segments of these
proteins [148, 149]. Flickering pores were detected
by electrophysiological measurements in experiments
with the related poliovirus [150–152] and with RV-
A2 [30], and via the release of co-internalized FITC-
dextran [153]. The amount of the dextran leaking
from virus-containing endosomes into the cytosol
was found to be inversely proportional to its size;
whereas 10 kD dextran exited, 70 kD dextran did
not. The membrane-disrupting adenovirus used as a
control released both dextrans equally well. This led
the authors to conclude that RV-A2 indeed formed
pores in the endosomal membrane and that the RNA
genome was most likely passed through such a pore
into the cytosol. These results were supported by
in vitro data demonstrating that the viral RNA could
be transferred from membrane-bound virions into
liposomes on acidification, and that the process was
accompanied by membrane permeabilization but not
disruption; the maximum RNA transfer occurred at a
virus concentration that only marginally impacted on
membrane integrity, again speaking for RNA transfer
through pores of limited size [82]. Finally, in vivo, RV-
A2 capsid proteins are readily degraded in lysosomes,
indicating that the virus shell does not attain the cy-
tosol. Proteolysis starts quite early; at about 30 min
post infection, all of VP1 and a large proportion of
VP2 had been cleaved [144]. Degradation of VP1 is
inhibited by the microtubule-disrupting drug noco-
dazole, which blocks transport from ECV to lysosomes
but leaves infection unaltered [143]. Nevertheless, it
is possible that, similar to calicivirus infection [154],
a marginal and thus difficult-to-detect cleavage of the
subviral shell already occurs in (late) endosomes and
facilitates RNA release in vivo.
Recently, it was demonstrated that RNA exit starts
from the 3’-end on heating to 56 °C in vitro [155], as
well as on physiologic endosomal acidification in vivo
[156]. Interestingly, upon acidification in vitro, exit
halted after about 700 bases had egressed. A simi-
lar phenomenon was seen in vivo; after conversion of
the native virion into the subviral A-particle, which
was observed at about 5 min post infection at 34 °C,
it took about 10 more minutes until the 700 3’-ter-
minal bases became accessible to added nuclease; at
lower temperature these times were prolonged. How-
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Tab. 1 Compilationof data referenced in the text. Upper panel, impact of pharmacological inhibitors, overexpressionof dom-
inant negativemutantproteins, or othermanipulationsonviral entry either tested via immunofluorescencemicroscopy (IFM)or
cleavageof eIF4Gand/or replicationbywildtypeRVsandvariants bindingheparansulfate, asexemplifiedbyRV-A8v.Note that
the inhibitorsofprotoncarriersandweakbases increasing thepHinendosomes—suchasniclosamide,monensin,methylamine,
etc.—inhibit uncoatingofminor-groupRVsstrongly andof somemajor-groupRVsweakly.Lower panel, colocalizationof viruses
with variousmarkersobservedbyfluorescencemicroscopy. For a list on themodeof actionof these inhibitors see [49]
Serotype/receptor group RV-A2/minor-group RV-B14 (major-group), entering via
ICAM-1
RV-A8v & other major-group entering via
HS












Chlorpromazine Not done Strong Not done Marginal Not done No
Filipin or nystatin Not done No Not done No Not done No
Methyl-ß-cyclodextrin Strong Weak Not done Weak Not done Weak
Amiloride or EIPA No Strong Not done Strong Not done Strong
Dynasore Strong Strong No Weak Not done Strong
Cytochalasin D No Weak Not done Weak Not done Strong
Bafilomycin No Strong Not done Weak Not done Not done
Amphi-SH3 Strong Not done No Not done No Not done
AP180-C Strong Not done No Not done No Not done
DynK44A Strong Not done No Not done Strong Not done
K-depletion Strong Not done Not done Not done Not done Not done
Rab5 S34N Strong Not done Not done Not done Not done Not done
Colocalization with
Transferrin Weak Not done No Not done No Not done
Flotillin-1 Not done Not done No Not done No Not done
CtxB Not done Not done No Not done No Not done
FITC-dextran Not done Not done Strong Not done Strong Not done
GFP-clathrin Not done Not done Not done Not done No Not done
Caveolin-1 No Not done Not done Not done No Not done
List of abbreviations: CtxB choleratoxin B, IFM immunofluorescence microscopy, Rab5 S34N Rab5 with S34 mutated to N, cvl cleavage, HS heparan sulphate,
obs observed
ever, all the remaining genome sequences were lost
from the viral shell at 34 °C within the next 2 min. It
was also found that the partial egress in vitro quickly
completed when amicrosomal fraction prepared from
HeLa cells was added. This suggests that cellular fa-
cilitators of the process might exist. Nevertheless, it
remains enigmatic how an RNAmolecule with a highly
complex secondary structure with many stems, loops,
and hairpins, should unfold to pass through a hole of
about 0.1 × 0.2 nm in the absence of energy consump-
tion in this short time.
Uptake and uncoating of the major receptor-
group prototype RV-B14
ICAM-1 lacks a clathrin localization signal but its cy-
toplasmic tail associates with alpha-actinin, thus con-
necting it to the cytoskeleton [157]. However, this as-
sociation is not required for viral uptake since the tail
and the transmembrane region can be replaced with
a glycosylphosphatidyl anchor without impact on vi-
ral infection [158]. Therefore, it is not unexpected
that chlorpromazine, which is moderately specific for
the clathrin-dependent pathway, and some dominant
negative mutant proteins involved in clathrin-depen-
dent endocytosis failed to block RV-B14 uptake (Tab. 1
and [33]). A particularly striking observation was the
accumulation of virions in long tubules connected
to the cell surface in RD and BHK-cells expressing
human ICAM-1 [33, 159]. Such aggregates had not
been reported for viruses internalized by clathrin-de-
pendent endocytosis, but were observed during entry
of SV40 when bound to the lipid receptor GM1 ([79]
and see above); nevertheless, in some instances, RV-
B14 in vesicles with a coat looking very similar to a
clathrin coat were seen in HeLa cells [159]. The sig-
nificance of this observation for viral uptake is un-
clear. Entry was strongly reduced by the Na(+)/H(+)
ion exchange inhibitor amiloride, and moderately re-
duced by the actin polymerization inhibitor cytocha-
lasin. Thus, it is highly likely that RV-B14 enters by
a non-clathrin- non-caveolin-dependent pathway re-
sembling macropinocytosis. Entry is slower than that
of RV-A2 and a large fraction of the virus appears
to be retained at the plasma membrane despite of
“normal” infection efficiency. As mentioned above,
RV-B14 probably arrives in the cytoplasm as a whole
(subviral) particle by disruption of the endosome [153,
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160]; this contention was also supported by the find-
ing that RV-B14 promotes endosomal release of trans-
fection complexes [161]. In summary, RV-B14 en-
ters via a pathway similar but not identical to typical
macropinocytosis (Fig. 3).
Uptake and uncoating of major receptor-group
viruses adapted to heparan sulfate proteoglycan
Identical to RV-B14, the serotypes RV-A8, RV-A54, and
RV-A89 all depend on ICAM-1 for entry and are thus
major-group RV [32]. The latter three were adapted to
use heparan sulfate (HS) as a receptor via blind pas-
sages alternating between HeLa and (ICAM-1-nega-
tive) Hep-2 cells. RV-A89 needed 34 such passages
[134, 162], RV-A8 three [32], and RV-A54 was found to
already be naturally adapted [34]. In all cases, bind-
ing to ICAM-1 was not lost but the viruses had become
less resistant to moderately acidic pH. This suggests
that in the absence of the “catalytic” activity of the re-
ceptor, the low pH alone must suffice for uncoating.
HS-binding variants were shown to strictly depend on
dynamin but not on clathrin, caveolin, and flotillin, as
summarized in Tab. 1 for the HS-adapted variant RV-
A8v, whose pathway was more extensively character-
ized; the same profile is probably seen with the other
HS-adapted variants. The tabulated data show that
entry via HS is similarly, but not identically sensitive
to inhibitors and manipulations as entry via ICAM-
1. Accumulation of the virions in tubules connected
to the plasma membrane was also observed [32]. Re-
cent work on uptake of wildtype RV-A89 (Conzemius
et al. manuscript submitted) indicates that this major-
group RV might involve clathrin for entry and uncoat
in the endosomal recycling compartment (Fig. 3).
Conclusion
Similar to the natural ligands of LDLR, minor-group
RVs follow the clathrin-dependent pathway for en-
try. Once inside endosomal carrier vesicles or late
endosomes, the low-pH environment triggers con-
version of the native virion into the A-particle, from
which, in a poorly-understood process, the RNA is
extruded through the endosomal membrane into the
cytosol. Major-group ICAM-1 binding viruses appear
to be taken up via a somewhat untypical form of
macropinocytosis. Both pathways converge in early
endosomes and the viruses are further shuttled to
late endosomes. Aided by the destabilizing activity of
ICAM-1 they are converted into A-particles with con-
comitant disruption of the endosomal membrane,
releasing the subviral particle or the empty particle
together with already uncoated RNA into the cytosol.
Finally, HS-adapted RVs follow a very similar pathway
but behave similar to minor-group RVs in being strin-
gently dependent on low pH for uncoating of the viral
genome. Repeated attempts to adapt a major-group
virus to use LDLR as a receptor failed. This indi-
cates that recognition of LDLR is not limited to mere
attraction of opposite charges. On the other hand,
the ubiquitous HS can be exploited for attachment
and entry but, at least in vivo, there must be other
more stringent requirements for not using it in nature.
The future might hold surprises regarding how RV-
C viruses are taken up by CDHR3 and routed inside
the host cell. Knowledge of how viruses enter the cell
and points of possible intervention is of paramount
importance for finding new ways of blocking infection
with drugs. Cellular targets are increasingly consid-
ered for this purpose as this minimizes resistance via
viral mutation.
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